Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer
激素受体阳性、HER2 阴性 II-III 期乳腺癌患者术前接受 Durvalumab 和 tremelimumab 治疗
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.28567
Haven R Garber, Sreyashi Basu, Sonali Jindal, Zhong He, Khoi Chu, Akshara Singareeka Raghavendra, Clinton Yam, Lumarie Santiago, Beatriz E Adrada, Padmanee Sharma, Elizabeth A Mittendorf, Jennifer K Litton